Partner Content Partner Content People with Chronic Conditions Concerned About “Returning to... People living with chronic conditions remain cautious
Events Partner Content Real-World Evidence 2020: Rare Diseases and Innovative Thera... Explore practical applications of RWE in rare diseases
Partner Content Partner Content PatchAi startup now in the market to support patients and cl... Healthware Ventures invested in PatchAi
Partner Content Partner Content Invitation to SMI’s Orphan Drugs & Rare Diseases Conference ... SMi reports: Invitation from conference co-chair released for the 9th Annual Orphan Drugs & Rare Diseases conference, taking place in London this October
Partner Content Partner Content Pre-Filled Syringes - Chemical Compatibility and Design Stra... Insight in Pre-Filled Syringe Deisgn
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
